Source-grounded facts extracted from Merlin, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Merlin, Inc. reported first quarter ended March 31, 2026 results: revenue $1.0 million, net income $(90.4) million.
“First quarter 2026 Total revenue of $1.0 million, compared to $0.9 million in the first quarter of 2025 ● First quarter 2026 GAAP net loss of $(90.4) million, compared to $(12.7) million in the first quarter of 2025”
Merlin, Inc. issued warrants exercisable for an aggregate of 4 million shares of Common Stock of warrant to the purchaser named therein for part of the Private Placement for aggregate gross proceeds of approximately $80 million.
“On April 29, 2026, Merlin, Inc., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement (the “ Purchase Agreement ”) with the purchaser named therein (the “ Purchaser ”), for the private placement (the “ Private Placement ”) of 8 million shares of the Company’s common stock, par value $0.0001 per share (the “ Shares ”), at a price per share of $10.00, and warrants (the “ Warrants ,” and together with the Shares, the “ Securities ”) exercisable for an aggregate of 4 million shares of Common Stock (the “ Underlying Shares ”), for aggregate gross proceeds of approximately $80 million.”
Merlin, Inc. issued 8 million shares of the Company’s common stock of common stock to the purchaser named therein for at a price per share of $10.00, for aggregate gross proceeds of approximately $80 million.
“On April 29, 2026, Merlin, Inc., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement (the “ Purchase Agreement ”) with the purchaser named therein (the “ Purchaser ”), for the private placement (the “ Private Placement ”) of 8 million shares of the Company’s common stock, par value $0.0001 per share (the “ Shares ”), at a price per share of $10.00, and warrants (the “ Warrants ,” and together with the Shares, the “ Securities ”) exercisable for an aggregate of 4 million shares of Common Stock (the “ Underlying Shares ”), for aggregate gross proceeds of approximately $80 million.”
Merlin, Inc. amended Second A&R Registration Rights Agreement with the Company and the Holders (as defined therein) of at least a majority in interest of the aggregate Registrable Securities (as defined therein) at the time of the amendment.
“the Amended and Restated Registration Rights Agreement, dated as of March 16, 2026, by and among the Company and the other parties thereto, was amended and restated by the Company and the Holders (as defined therein) of at least a majority in interest of the aggregate Registrable Securities (as defined therein) at the time of the amendment (the “ Second A&R Registration Rights Agreement ”).”
Merlin, Inc. entered into Purchase Agreement with the purchaser named therein valued at aggregate gross proceeds of approximately $80 million (effective 2026-04-29).
“Merlin, Inc., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement (the “ Purchase Agreement ”) with the purchaser named therein (the “ Purchaser ”), for the private placement (the “ Private Placement ”) of 8 million shares of the Company’s common stock, par value $0.0001 per share (the “ Shares ”), at a price per share of $10.00, and warrants (the “ Warrants ,” and together with the Shares, the “ Securities ”) exercisable for an aggregate of 4 million shares of Common Stock (the “ Underlying Shares ”), for aggregate gross proceeds of approximately $80 million.”
Merlin, Inc. issued 9,803,922 shares of Series A Preferred Stock and 1,666,668 shares of Series A Preferred Stock of preferred stock to PIPE Investors for total purchase price of $100.0 million and $20 million respectively.
“Inflection Point issued and sold to the PIPE Investors (substantially concurrently with the consummation of the Transactions) an aggregate of (i) 9,803,922 shares of the Series A Preferred Stock and (ii) New Merlin Series A Warrants to purchase shares of Common Stock, for a total purchase price of $100.0 million (the “ Initial PIPE Investment ”).”
Merlin, Inc.: Inflection Point ceased being a shell company as a result of the Transactions.
“As a result of the Transactions, Inflection Point ceased being a shell company.”
Merlin, Inc.: Filed Certificate of Incorporation with the State of Delaware in connection with Domestication (effective 2026-03-13).
“On March 13, 2026, in connection with the Domestication, the Company filed the Certificate of Incorporation with the Secretary of State of the State of Delaware.”
Merlin, Inc. entered into Securities Purchase Agreements with Inflection Point, Legacy Merlin and certain investors (collectively, the 'PIPE Investors') valued at total purchase price of $100.0 million (effective 2025-08-13).
“Pursuant to the securities purchase agreements (as amended and supplemented, the “ Securities Purchase Agreements ”) entered into on August 13, 2025 and as amended on November 17, 2025, by and among Inflection Point, Legacy Merlin and certain investors (collectively, the “ PIPE Investors ”), Inflection Point issued and sold to the PIPE Investors (substantially concurrently with the consummation of the Transactions) an aggregate of (i) 9,803,922 shares of the Series A Preferred Stock and (ii) New Merlin Series A Warrants to purchase shares of Common Stock, for a total purchase price of $100.0 million (the “ Initial PIPE Investment ”).”
Merlin, Inc. entered into A&R Registration Rights Agreement with the Company, the Sponsor, certain persons and entities receiving shares of New Merlin Common Stock (the 'Merlin Stockholders'), and other parties.
“On the Closing Date, in connection with the consummation of the Transactions and as contemplated by the Business Combination Agreement, the Company, the Sponsor, certain persons and entities receiving shares of New Merlin Common Stock in connection with the Business Combination (the “ Merlin Stockholders ”), and other parties thereto entered into the Amended and Restated Registration Rights Agreement (the “ A&R Registration Rights Agreement ”), pursuant to which, among other things, the Sponsor, the Merlin Stockholders and other parties thereto will be granted certain customary registration rights, on the terms and subject to the conditions therein, with respect to securities of the Company that they hold following the Business Combination.”
Merlin, Inc. entered into Merlin Lock-Up Agreement with certain equity holders of Legacy Merlin.
“On the Closing Date, in connection with the consummation of the Transactions and as contemplated by the Business Combination Agreement the Company and certain equity holders of Legacy Merlin entered into the Merlin Lock-Up Agreement (the “ Merlin Lock-Up Agreement ”), pursuant to which the Merlin Lock-Up Holders agreed not to, among other things, sell, pledge, grant any option to purchase or otherwise dispose of the Lock-Up Shares, prior to the date that is six months after the Closing Date.”
Merlin, Inc. entered into Sponsor Lock-Up Agreement with the Sponsor.
“On the Closing Date, in connection with the consummation of the Transactions and as contemplated by the Business Combination Agreement, the Company and the Sponsor entered into the Sponsor Lock-Up Agreement (the “ Sponsor Lock-Up Agreement ”), pursuant to which the Sponsor and its permitted assigns agreed, among other things, not to sell, pledge, grant any option to purchase or otherwise dispose of (i) the Sponsor Lock-Up Shares prior to the date that is six months after the Closing Date and (ii) the Sponsor Lock-Up Units prior to the date that is 90 days after the Closing Date.”
Merlin, Inc. completed an acquisition involving Merlin Labs, Inc. (Legacy Merlin) for 75,764,313 shares of New Merlin Common Stock valued at $800,000,000, plus 10,244,861 shares of Series A Preferred Stock for Pre-Funded Convertible Note holders (closed 2026-03-16).
“Holders ”) (other than the holders of the Pre-Funded Convertible Notes and the Pre-Funded Warrants in respect of those securities) in, or in connection with, the Merger was 75,764,313 shares of New Merlin Common Stock. The Aggregate Consideration was calculated as the number of shares of New Merlin Common Stock equal to the quotient of: (a) $800,000,000 (the “”
Merlin, Inc. engaged BDO USA, P.C. (f/k/a HORNE LLP) as its auditor.
“On March 16, 2026, the Audit Committee approved the engagement of BDO as the Company’s independent registered public accounting firm to audit the Company’s consolidated financial statements for the year ending December 31, 2026.”
Merlin, Inc. dismissed WithumSmith+Brown, PC as its auditor.
“On March 16, 2026, the Audit Committee dismissed WithumSmith+Brown, PC (“ Withum ”), Inflection Point’s independent registered public accounting firm prior to consummation of the Transactions, as the Company’s independent registered public accounting firm effective immediately.”
Merlin, Inc. issued 1,666,668 shares of New Merlin Labs Preferred Stock and Closing Warrants to purchase a number of shares of New Merlin Labs Common Stock that is equal to 75% of of convertible note to Additional Closing PIPE Investors for aggregate purchase price not specified.
“Inflection Point and Merlin Labs also entered into Securities Purchase Agreements, dated November 17, 2025 (the “ Additional Closing PIPE Subscription Agreements ”), with certain accredited investors signatory thereto (the “ Additional Closing PIPE Investors ”), pursuant to which, among other things, the Additional Closing PIPE Investors agreed to purchase, and Inflection Point agreed to sell, an aggregate of 1,666,668 shares of New Merlin Labs Preferred Stock and Closing Warrants to purchase a number of shares of New Merlin Labs Common Stock that is equal to 75% of the amount of shares into which such shares of New Merlin Labs Common Stock underlying the New Merlin Labs Preferred Stock are initially convertible, in a private placement, on substantially the same terms as the Closing PIPE Subscription Agreement”
Merlin, Inc. issued 9,803,922 shares of New Merlin Labs Preferred Stock and a Closing Warrant to purchase a number of shares of New Merlin Labs Common Stock equal to the amount of of convertible note to accredited investors (Closing PIPE Investor and Additional Closing PIPE Investors) for aggregate purchase price of $100,000,000 (increase from $50,000,000) for the Closing PIPE Investment; aggregate purchase price for Additional Closing PIPE Inves.
“On November 17, 2025, Inflection Point and Merlin Labs entered into an amendment to the Closing PIPE Subscription Agreement with the Closing PIPE Investor (“ Amendment No. 1 to the Closing PIPE Subscription Agreement ”), pursuant to which the Closing PIPE Investor agreed to increase its Closing PIPE Investment to $100,000,000, for which it will receive 9,803,922 shares of New Merlin Labs Preferred Stock and a Closing Warrant to purchase a number of shares of New Merlin Labs Common Stock equal to the amount of shares into which such shares of New Merlin Labs Common Stock underlying the New Merlin Labs Preferred Stock are initially convertible, on the same terms and conditions as the Closing PIPE Subscription Agreement.”
Merlin, Inc.: Amended Article 50.5 of the Articles to allow earlier redemption of public shares in connection with a business combination (effective 2025-10-21).
“to delete in its entirety current Article 50.5 thereof and replace it”
Merlin, Inc.: Amended the Articles to change company name from Bleichroeder Acquisition Corp. I to Inflection Point Acquisition Corp. IV (effective 2025-10-21).
“On October 21, 2025, the shareholders of Inflection Point Acquisition Corp. IV (f/k/a Bleichroeder Acquisition Corp. I, the “ Company ”) approved the Name Change Proposal”
Kathy Savitt was appointed as Chair of the Audit Committee at Merlin, Inc..
“the Board appointed Kathy Savitt as the Chair of the Audit Committee of the Company.”
Nazim Cetin resigned as Chair of the Audit Committee at Merlin, Inc..
“Nazim Cetin resigned as the Chair of the Audit Committee effective April 8, 2025, but will continue to serve as a member of the Audit Committee.”
Marcello Padula was appointed as Chief Financial Officer at Merlin, Inc..
“On April 10, 2025, the Board appointed Marcello Padula to serve as the Chief Financial Officer of the Company, effective on May 7, 2025.”
Robert Folino resigned as Chief Financial Officer at Merlin, Inc..
“On April 4, 2025, Robert Folino notified the board of directors (the “Board”) of Bleichroeder Acquisition Corp. I (the “Company”) of his resignation as Chief Financial Officer of the Company, effective on May 7, 2025.”
Merlin, Inc.: Filed amended and restated memorandum and articles of association, effective October 31, 2024, in connection with the IPO (effective 2024-10-31).
“On October 31, 2024, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “ Amended and Restated Memorandum and Articles of Association ”) with the Cayman Islands Registrar of Companies, which was effective on October 31, 2024.”
Pierre Weinstein was appointed as Director at Merlin, Inc..
“On November 1, 2024, in connection with the IPO, Nazim Cetin, Joseph Samuels, Kathy Savitt, Antoine Theysset and Pierre Weinstein (collectively with Andrew Gundlach, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).”
Antoine Theysset was appointed as Director at Merlin, Inc..
“On November 1, 2024, in connection with the IPO, Nazim Cetin, Joseph Samuels, Kathy Savitt, Antoine Theysset and Pierre Weinstein (collectively with Andrew Gundlach, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).”
Kathy Savitt was appointed as Director at Merlin, Inc..
“On November 1, 2024, in connection with the IPO, Nazim Cetin, Joseph Samuels, Kathy Savitt, Antoine Theysset and Pierre Weinstein (collectively with Andrew Gundlach, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).”
Joseph Samuels was appointed as Director at Merlin, Inc..
“On November 1, 2024, in connection with the IPO, Nazim Cetin, Joseph Samuels, Kathy Savitt, Antoine Theysset and Pierre Weinstein (collectively with Andrew Gundlach, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).”
Nazim Cetin was appointed as Director at Merlin, Inc..
“On November 1, 2024, in connection with the IPO, Nazim Cetin, Joseph Samuels, Kathy Savitt, Antoine Theysset and Pierre Weinstein (collectively with Andrew Gundlach, the “ Directors ”) were appointed to the board of directors of the Company (the “ Board ”).”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.